or Try an Advanced Search...

    Organ Systems Stocks List

    Symbol Grade Name % Change
    AKTX F Akari Therapeutics Plc 4.84
    ANVS F Annovis Bio, Inc. -2.06
    NRBO F NeuroBo Pharmaceuticals, Inc. 0.85
    MSOS F AdvisorShares Pure US Cannabis ETF -2.63
    OCGN F Ocugen, Inc. 0.72
    ARWR F Arrowhead Research Corporation 1.42
    TERN F Terns Pharmaceuticals, Inc. 1.40
    CNTX F Context Therapeutics Inc. -7.33
    BBIO F BridgeBio Pharma, Inc. 0.77
    OPTN F OptiNose, Inc. 21.52
    View As Page of Charts
    Related Industries: Biotechnology Data Storage Drug Manufacturers - General Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Marketing Services Medical Appliances & Equipment Medical Devices Medical Instruments & Supplies Shell Companies
    Related Stock Lists: Biopharmaceutical Amyloid Clinical Medicine Medicine Neurodegeneration Obesity Achondroplasia Acquired Hemolytic Anemia Allergy Alzheimer's Disease Amyloidosis Anti Diabetic Drugs Antineoplastic Drugs Antiprogestogens Apoptosis Autoimmune And Inflammatory Disease Autoimmunity Bile Acid Biology Blindness

    Related ETFs - A few ETFs which own one or more of the above listed Organ Systems stocks.

    Symbol Grade Name Weight
    YOLO F AdvisorShares Pure Cannabis ETF 39.73
    HRTS F Tema Cardiovascular and Metabolic ETF 6.15
    GNOM F Global X Genomics & Biotechnology ETF 4.07
    WDNA F WisdomTree BioRevolution Fund 2.39
    OZEM F Roundhill GLP-1 & Weight Loss ETF 1.97
    View all Organ Systems ETFs...
    Compare ETFs
    Compare HRTS to WDNA Compare WDNA to OZEM Compare YOLO to GNOM

        Organ Systems Stocks Recent News

        Date Stock Title
        Nov 23 BBIO Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients
        Nov 22 ARWR Arrowhead Pharmaceuticals Inc. (ARWR): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts
        Nov 22 MSOS Marijuana Industry Could Stay in Limbo Under Trump
        Nov 21 BBIO Why Is BridgeBio Pharma, Inc. (BBIO) Among the Worst Performing Biotech Stocks in 2024?
        Nov 21 MSOS Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
        Nov 21 MSOS Cannabis Stocks Drop on Matt Gaetz Withdrawal
        Nov 20 OCGN Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate OCU410ST for Treatment of ABCA4-Associated Retinopathies including Stargardt Disease
        Nov 19 BBIO BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market
        Nov 19 OCGN Ocugen reports positive data for OCU400, OCU410
        Nov 19 AKTX Akari Therapeutics Regains Full Nasdaq Compliance
        Nov 19 TERN Top 3 Health Care Stocks You'll Regret Missing In Q4
        Nov 19 OCGN Ocugen Announces Compelling Preliminary Data for OCU410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
        Nov 19 BBIO The Consensus EPS Estimates For BridgeBio Pharma, Inc. (NASDAQ:BBIO) Just Fell Dramatically
        Nov 18 TERN Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors
        Nov 18 BBIO Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months
        Nov 18 NRBO NeuroBo Pharmaceuticals Announces Strategic Realignment Ahead of Important Clinical Milestones with Name Change to MetaVia - Reflecting the Company's Focus on Cardiometabolic Diseases
        Nov 18 ARWR Arrowhead Pharmaceuticals Submits New Drug Application to U.S. FDA for Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
        Nov 18 ARWR Arrowhead Pharmaceuticals Presents New Data at AHA24 from PALISADE Phase 3 Study and Open-Label Extension from MUIR and SHASTA-2 Studies of Plozasiran
        Nov 18 BBIO BridgeBio Pharma Announces Publication in the New England Journal of Medicine of Phase 2 PROPEL 2 Study of Infigratinib for Children Living with Achondroplasia
        Related Industries: Biotechnology Data Storage Drug Manufacturers - General Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Marketing Services Medical Appliances & Equipment Medical Devices Medical Instruments & Supplies Shell Companies
        Related Stock Lists: Biopharmaceutical Amyloid Clinical Medicine Medicine Neurodegeneration Obesity Achondroplasia Acquired Hemolytic Anemia Allergy Alzheimer's Disease Amyloidosis Anti Diabetic Drugs Antineoplastic Drugs Antiprogestogens Apoptosis Autoimmune And Inflammatory Disease Autoimmunity Bile Acid Biology Blindness
        Organ Systems

        Organ systems are groups of organs that work together to perform a specific function or set of functions in the body. Examples of organ systems include the digestive system, the respiratory system, the circulatory system, the nervous system, the endocrine system, the reproductive system, the skeletal system, and the muscular system.

        Browse All Tags